A key opinion leader discusses effective risk prevention measures and challenges to reducing adverse events. He also considers effective educational resources for self-care.
American Heart Association Launches Initiative to Include Pharmacists in Atrial Fibrillation Care
Despite a wealth of knowledge, pharmacists are frequently not consulted as part of the decision-making team in atrial fibrillation management.
Buyer Beware: Red Yeast Rice Supplements Linked to Deaths, Hospitalizations
Japan’s health ministry has issued a warning to consumers regarding red yeast rice dietary supplements containing a red species of mold after 5 people died and more were hospitalized after consumption.
FDA Approves Vadadustat For Treatment of Anemia Due to CKD
The approval of vadadustat (Vafseo) from Akebia Therapeutics was based on data from the phase 3 INNO2VATE program.
Improving CVD Outcomes Through Better Recommendations, Patient Monitoring
Researchers detailed the FDA’s recommendations on low-dose aspirin and pharmacists’ role in cardiovascular practice transformation programs.
FDA Approves Sotatercept-csrk for Pulmonary Arterial Hypertension
The drug had previously been granted a breakthrough therapy designation by the FDA.
FDA Approves Label Expansions, New Indication for Bempedoic Acid Tablets for CV Prevention
The approval represents the first non-statin treatment indicated to lower low-density lipoprotein for primary prevention patients.